Sign In
Buy DHR
$178.08
+1.97 (+1.12%)
At Close: Jun 03, 2026
Got $500? 3 Blue Chip Dividend Stocks to Buy and Hold Forever
04:20am, Wednesday, 30'th Jul 2025
Often, great investing boils down to holding on to great stocks. It can be as simple as that.
International Markets and Danaher (DHR): A Deep Dive for Investors
11:50am, Monday, 28'th Jul 2025
Explore how Danaher's (DHR) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Investors decided the good outweighs the bad with Danaher, says Jim Cramer
08:08pm, Thursday, 24'th Jul 2025
'Mad Money' host Jim Cramer talks how to play Danaher after earnings.
Danaher Q2 2025 Update
03:30pm, Thursday, 24'th Jul 2025
While the worst seem to be behind them, the business isn't quite humming enough to get investors excited yet. Revenue growth guidance for 2025 remains unchanged at 3%. But they did raise full year adj
CVS or DHR: Which Is the Better Value Stock Right Now?
12:41pm, Thursday, 24'th Jul 2025
Investors interested in Medical Services stocks are likely familiar with CVS Health (CVS) and Danaher (DHR). But which of these two stocks is more attractive to value investors?
Here's Why Danaher (DHR) is a Strong Growth Stock
10:45am, Wednesday, 23'rd Jul 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Danaher Stock: Attractively Valued And Poised For Growth Acceleration
09:50am, Wednesday, 23'rd Jul 2025
Danaher Corporation is returning to growth, led by strong bioprocessing demand and resilient diagnostics, with Life Sciences expected to recover in late 2025. Margins may face short-term pressure, but
Danaher Raises 2025 Earnings Outlook
05:04pm, Tuesday, 22'nd Jul 2025
Danaher (DHR 0.98%) reported its second-quarter 2025 results on July 22, 2025, with sales of $5.9 billion and core revenue growth of 1.5% year over year. Adjusted diluted EPS grew 5% to $1.80, free ca
Danaher Beats Q2 Revenue, EPS Forecasts
04:12pm, Tuesday, 22'nd Jul 2025
Global science and technology innovator Danaher (DHR 1.08%) reported second quarter 2025 results on Tuesday, July 22, that topped analysts' consensus expectations. Q2 revenue of $5.94 billion came in
Danaher Corporation (DHR) Q2 2025 Earnings Call Transcript
01:18pm, Tuesday, 22'nd Jul 2025
Danaher Corporation (NYSE:DHR ) Q2 2025 Earnings Conference Call July 22, 2025 8:00 AM ET Company Participants John Bedford - Vice President of Investor Relations Matthew R. McGrew - CFO & Executive V
Danaher Q2 Earnings Beat Estimates, Life Sciences Sales Up Y/Y
12:15pm, Tuesday, 22'nd Jul 2025
DHR tops Q2 estimates with strong sales across segments, lifting its 2025 EPS outlook amid mixed margin trends.
Cramer's Stop Trading: Danaher
10:33am, Tuesday, 22'nd Jul 2025
Jim Cramer breaks down why he's keeping an eye on shares of Danaher.
Danaher (DHR) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
10:30am, Tuesday, 22'nd Jul 2025
The headline numbers for Danaher (DHR) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
Danaher (DHR) Q2 Earnings and Revenues Top Estimates
08:10am, Tuesday, 22'nd Jul 2025
Danaher (DHR) came out with quarterly earnings of $1.8 per share, beating the Zacks Consensus Estimate of $1.64 per share. This compares to earnings of $1.72 per share a year ago.
Danaher lifts annual profit view on strength in diagnostics, names new CFO
07:51am, Tuesday, 22'nd Jul 2025
Life sciences firm Danaher raised its annual profit forecast on Tuesday, banking on resilient demand for its diagnostic testing tools and services.
